Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shigella Conjugate Vaccines in Israeli Children
NCT00368316Phase 3Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Jan 2003
- Primary completion
- Jan 2008
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Shigella sonnei-CRM9, Shigella flexneri 2a-rEPAsucc in shigellosis, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Jan 2003; status: completed.
02
Drugs
Shigella sonnei-CRM9Shigella flexneri 2a-rEPAsucc
03
Conditions
shigellosis
Beyond the preview
Go deeper on NCT00368316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368316.